Buschmann Jonas, Seiler Theresa, Bernhardt Günther, Keller Max, Wifling David
Institute of Pharmacy , Faculty of Chemistry and Pharmacy , University of Regensburg , Universitätsstrasse 31 , D-93053 Regensburg , Germany . Email:
RSC Med Chem. 2020 Jan 20;11(2):274-282. doi: 10.1039/c9md00538b. eCollection 2020 Feb 1.
The recently resolved crystal structure of the neuropeptide Y Y receptor (YR), co-crystallized with the high-affinity (p : 10.11), argininamide-type YR antagonist UR-MK299 (), revealed that the -carbamoyl substituent (van der Waals volume: 139 Å) is deeply buried in the receptor, occupying a hydrophobic pocket. We synthesized and characterized a series of argininamides, structurally related to . YR affinity decreased with increasing size of the carbamoyl residue (minimal p : 5.67). Exceeding a critical size of the substituent (van der Waals volume: 212 Å), the ligands bound in an inverted mode with the carbamoyl side chain located at the surface of the receptor, as suggested by induced-fit docking and MD simulations.
最近解析的神经肽Y Y受体(YR)的晶体结构,与高亲和力(pKi:10.11)的精氨酰胺型YR拮抗剂UR-MK299共结晶,结果显示,α-氨基甲酰基取代基(范德华体积:139 Å)深埋于受体中,占据一个疏水口袋。我们合成并表征了一系列与UR-MK299结构相关的精氨酰胺。随着氨基甲酰基残基尺寸的增加,YR亲和力降低(最小pKi:5.67)。超过取代基的临界尺寸(范德华体积:212 Å)时,如诱导契合对接和分子动力学模拟所示,配体以反向模式结合,氨基甲酰基侧链位于受体表面。